Global Cell Surface Markers Detection Market Driven by Rising Adoption of Flow Cytometry and Increasing Cancer Immunotherapy Research and Stem Cell Analysis

Insights into Market Size, Trends, Market Dynamics, Key Segments, and Emerging Players

Straits Research, a leading market research organization, announced the release of the report titled “Cell Surface Makers Detection Market Size and Outlook —Forecasts till 2034”. The report provides an in-depth analysis of the market size, trends, opportunities, and market mechanism. The report also covers a regional analysis of several market factors.

According to the report, the market is valued at USD 7.01 billion in 2026, which is expected to grow to USD 13.33 billion by 2034. The projected CAGR for this period is 8.36%.

The cell surface makers detection market is segmented based on product, application, and region. Some of the insights provided in the report are highlighted below:

• The reagents & kits segment dominated the market with the largest share of 66.78% in 2025.
• North America is expected to lead the cell surface markers detection market during the forecast period, supported by strong presence of advanced research infrastructure and high adoption of flow cytometry and immunophenotyping technologies.
• Healthcare and research organizations globally are shifting toward targeted and multi-parameter cell surface marker detection approaches to improve diagnostic accuracy, enable precise cell characterization, and support advancements in oncology, immunology, and stem cell research.
• India is projected to emerge as a fast-growing market in the Asia Pacific cell surface markers detection market, driven by expanding biomedical research activities and increasing investments in biotechnology and life sciences.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.

Market Segments

1. By Product
   1. Flow Cytometry
   2. Hematology Analyzers
   3. Reagents & Kits
2. By Application
   1. Disease Diagnosis & Identification
   2. Research & Drug Discovery
   3. Others
3. By Region
   1. North America
   2. Europe
   3. Asia Pacific
   4. Middle East & Africa
   5. Latin America